-
301
Challenges in the Diagnosis and Management of Patients with Fibrosing Interstitial Lung Disease
Published 2022-01-01“…Patients with some fibrosing ILDs may respond well to immunosuppressants, but even patients who respond well to immunosuppressants initially may later show deterioration despite appropriate management. …”
Get full text
Article -
302
Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment
Published 2025-02-01“…This review explores the molecular mechanisms of action of HIF-1α in IVM, its impact on immunotherapy resistance, as well as potential interventions, emphasizing the need for innovative approaches to circumvent hypoxia-driven immunosuppression in cancer therapy.…”
Get full text
Article -
303
Free Radical Scavenging Capacities and Alleviating Actions of Polysaccharides Extract of Termitomyces le-testui on Methylprednisolone-Induced Immunodepression in Rats
Published 2021-01-01“…Hot water extract of polysaccharide extract of T. le-testui was prepared and tested in white albino Wister rats for its immunomodulatory activities effect on methylprednisolone-immunosuppressed animals. In addition, the radical scavenging activity of the polysaccharide was evaluated using nitrite and hydrogen peroxide. …”
Get full text
Article -
304
Biology of extracellular vesicles and the potential of tumor-derived vesicles for subverting immunotherapy of cancer
Published 2025-01-01“…Immunosuppressive molecular profiles and abilities to signal, enter and functionally reprogram a variety of recipient cells enable TEX to exert pro-tumor effects that promote tumor resistance to immunotherapy. …”
Get full text
Article -
305
Immunological Remission as a Basis for Dose Reduction of Immunosuppressors in Autoimmune Hepatitis: Results of Monocenter Surveillance Study
Published 2024-03-01“…The data of 47 patients with AIH who received immunosuppressive therapy from April 2001 to August 2023 were analyzed: 10 men (21 %), 37 women (79 %); the average age was 37 (17–66) years. …”
Get full text
Article -
306
YAP1 as a Novel Negative Biomarker of Immune Checkpoint Inhibitors for EGFR-Mutant Non-Small-Cell Lung Cancer
Published 2023-01-01“…Conclusions. YAP1 mediates immunosuppressive microenvironment and poor prognosis in EGFR-mutant NSCLC population. …”
Get full text
Article -
307
Pulmonary Nocardiosis in the Immunocompetent Host: Case Series
Published 2015-01-01“…Pulmonary nocardiosis is commonly recognized as an opportunistic infection in patients with predisposing immunosuppressive conditions. However, reports of pulmonary nocardiosis in the immunocompetent host are rare. …”
Get full text
Article -
308
Wickerhamomyces anomalous: A Rare Cause of Fungemia Causing Febrile Neutropenia in Acute Lymphoblastic Leukemia
Published 2020-01-01“…Here, we report a case of catheter-related bloodstream infection (CRBSI) caused by W. anomalus in a leukemic immunosuppressed patient who was successfully treated by early detection and treatment of this emerging fungus.…”
Get full text
Article -
309
Divergent Effects of <i>Circoviridae</i> Capsid Proteins on Type I Interferon Signaling
Published 2025-01-01“…Additionally, beak and feather disease virus in parrots, canine circovirus in dogs, and columbid circovirus (pigeon circovirus) in racing pigeons induce immunosuppression, followed by secondary infections in these hosts. …”
Get full text
Article -
310
ACSL4 promotes the formation of the proliferative subtype in hepatoblastoma
Published 2025-02-01“…Among them, the proliferative subtype, characterized by enhanced proliferative capacity, poor prognosis, and an immunosuppressive tumor microenvironment, was particularly notable. …”
Get full text
Article -
311
Basic Molecular Biology, Metabolic and Immunological Mechanisms of Fecal Microbiota Transplantation
Published 2024-12-01“…This complication required resumption and subsequent intensification of immunosuppressive therapy with complete resolution of GVHD symptoms. …”
Get full text
Article -
312
Transverse Myelitis Associated with Cryptococcus neoformans in an Immunocompetent Patient
Published 2022-01-01“…Cryptococcal infections are known to cause significant morbidity and mortality in immunosuppressed patients as it is difficult to eradicate even with adequate antifungal treatment. …”
Get full text
Article -
313
Hepatitis C Virus, Cryoglobulinemia, and Kidney: Novel Evidence
Published 2012-01-01“…Various approaches have been tried for the treatment of HCV-related glomerulonephritis, including immunosuppressive therapy (corticosteroids and cytotoxic agents), plasma exchange and antiviral agents. …”
Get full text
Article -
314
Targeted therapy for pancreatic ductal adenocarcinoma: Mechanisms and clinical study
Published 2023-04-01“…Contributing to the poor prognosis of PDAC is the lack of early detection, a complex network of signaling pathways and molecular mechanisms, a dense and desmoplastic stroma, and an immunosuppressive tumor microenvironment. A recent shift toward a neoadjuvant approach to treating PDAC has been sparked by the numerous benefits neoadjuvant therapy (NAT) has to offer compared with upfront surgery. …”
Get full text
Article -
315
Glioblastoma Multiforme Stem Cells
Published 2011-01-01“…Therefore, a comprehensive understanding of the mechanisms underlying the GBM-induced immunosuppression is indispensable. This review presents a summary of the present knowledge both on GBMSCs and the GBM, and/or GBMSC-related mechanisms of developing both local and systemic immunosuppression, of which an understanding may lead to the development of the novel and effective therapeutic strategies.…”
Get full text
Article -
316
Pancreatitis in systemic lupus erythematosus: Clinical characterization and outcome analysis in concurrent pancreatitis and lupus
Published 2021-01-01“…All our patients were treated with high-dose steroids and other immunosuppression as indicated for concomitant disease activity. …”
Get full text
Article -
317
Coinfections increase the risk of HIV acquisition, AIDS progression, and therapy and prophylaxis failure: a review
Published 2024-08-01“…The primary drivers of preexisting immunosuppression and inflammation are non-HIV infections and possibly alloantigen and drug exposures. …”
Get full text
Article -
318
Lymphatic-derived oxysterols promote anti-tumor immunity and response to immunotherapy in melanoma
Published 2025-01-01“…Abstract In melanoma, lymphangiogenesis correlates with metastasis and poor prognosis and promotes immunosuppression. However, it also potentiates immunotherapy by supporting immune cell trafficking. …”
Get full text
Article -
319
Tacrolimus toxicity management in a pregnant kidney transplant recipient with newly diagnosed human immunodeficiency virus: A case report
Published 2025-02-01“…Managing kidney transplant recipients during pregnancy presents significant challenges, particularly in balancing the interactions and safety concerns of immunosuppressive medications such as mycophenolate mofetil and tacrolimus. …”
Get full text
Article -
320
SLE and Non-Hodgkin’s Lymphoma: A Case Series and Review of the Literature
Published 2017-01-01“…We will also review and discuss the implications of immunosuppressives in SLE-related lymphoma and the role of mycophenolate mofetil in SLE-related primary CNS lymphoma development.…”
Get full text
Article